Zepbound News

Zepbound: Why Setting Weight Loss Goals May Be Key to Success - Healthline

Zepbound: Why Setting Weight Loss Goals May Be Key to Success Healthline

Researchers Expected Ozempic Weight Loss to Boost Exercise. It Didn’t - SciTechDaily

Researchers Expected Ozempic Weight Loss to Boost Exercise. It Didn’t SciTechDaily

Up to 14M Medicare patients could be eligible for GLP-1s for just $50 a month — here's who qualifies - New York Post

Up to 14M Medicare patients could be eligible for GLP-1s for just $50 a month — here's who qualifies New York Post

Which GLP-1 medication is most effective for weight loss? - UGA Today

Which GLP-1 medication is most effective for weight loss? UGA Today

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans - CNBC

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans CNBC

CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash - NBC News

CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash NBC News

Foundayo and Zepbound now covered for millions of Americans - PR Newswire

Foundayo and Zepbound now covered for millions of Americans PR Newswire

CVS will add these weight-loss options to drug plans - USA Today

CVS will add these weight-loss options to drug plans USA Today

A new Medicare option for weight loss drugs is coming: Here's what to know - NPR

A new Medicare option for weight loss drugs is coming: Here's what to know NPR

CVS brings back coverage for Lilly's obesity drug Zepbound - Reuters

CVS brings back coverage for Lilly's obesity drug Zepbound Reuters

Primary care doctors raise alarm as telehealth companies get involved in obesity drugs - NPR

Primary care doctors raise alarm as telehealth companies get involved in obesity drugs NPR

Zepbound® (tirzepatide) and Shaquille O'Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable - PR Newswire

Zepbound® (tirzepatide) and Shaquille O'Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable PR Newswire

Foundayo and Zepbound now covered for millions of Americans | Eli Lilly and Company - investor.lilly.com

Foundayo and Zepbound now covered for millions of Americans | Eli Lilly and Company investor.lilly.com

Medicare and Weight-Loss Drugs: Coverage Expansion in 2026 - GoodRx

Medicare and Weight-Loss Drugs: Coverage Expansion in 2026 GoodRx

Millions of older Americans soon could get popular weight loss drugs for $50 a month, far less than today's prices - UCHealth

Millions of older Americans soon could get popular weight loss drugs for $50 a month, far less than today's prices UCHealth

People Walk, Exercise Less After Starting Ozempic, Zepbound - U.S. News & World Report

People Walk, Exercise Less After Starting Ozempic, Zepbound U.S. News & World Report

GLP-1 Weight-Loss Drug Demonstration Begins July 2026 - Medicare Rights Center

GLP-1 Weight-Loss Drug Demonstration Begins July 2026 Medicare Rights Center

Will Zepbound get cheaper? Ways to lower your costs now - Medical News Today

Will Zepbound get cheaper? Ways to lower your costs now Medical News Today

CVS obesity drug deal puts Lilly on equal footing with Novo - Healthcare Dive

CVS obesity drug deal puts Lilly on equal footing with Novo Healthcare Dive

Eli Lilly says its next gen obesity drug is more powerful than Zepbound and Wegovy - NPR

Eli Lilly says its next gen obesity drug is more powerful than Zepbound and Wegovy NPR

Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials - investor.lilly.com

Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials investor.lilly.com

Shaquille O’Neal Shares How Zepbound Helped with Sleep Apnea and Weight Loss - Healthline

Shaquille O’Neal Shares How Zepbound Helped with Sleep Apnea and Weight Loss Healthline

Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it - NPR

Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it NPR

Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen - investor.lilly.com

Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen investor.lilly.com

Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases - Reuters

Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases Reuters

CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo - Fierce Pharma

CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo Fierce Pharma

Health Canada approves ZEPBOUND® as the first-ever obstructive sleep apnea medication in Canada for adults living with obesity - Newswire Canada

Health Canada approves ZEPBOUND® as the first-ever obstructive sleep apnea medication in Canada for adults living with obesity Newswire Canada

GLP-1s appear to protect against cancer. Researchers are trying to figure out how - NPR

GLP-1s appear to protect against cancer. Researchers are trying to figure out how NPR

CVS Caremark to cover Zepbound again after lawsuit, widespread backlash - LiveNOW from FOX

CVS Caremark to cover Zepbound again after lawsuit, widespread backlash LiveNOW from FOX

Forget Zepbound: Eli Lilly's Next Billion-Dollar Weight-Loss Drug May Be Even Better - The Motley Fool

Forget Zepbound: Eli Lilly's Next Billion-Dollar Weight-Loss Drug May Be Even Better The Motley Fool

Some Medicare recipients may soon get Wegovy, Zepbound for $50 a month - Click2Houston

Some Medicare recipients may soon get Wegovy, Zepbound for $50 a month Click2Houston

Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect - investor.lilly.com

Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect investor.lilly.com

Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight - investor.lilly.com

Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight investor.lilly.com